期刊文献+

Aβ25-35对SH-SY5Y细胞Bcl-2、Bax基因启动子区DNA甲基化的影响 被引量:5

Effect of Aβ_(25-35) on Bcl-2,Bax gene promoter DNA methylation in SH-SY5Y cell
在线阅读 下载PDF
导出
摘要 目的探讨Aβ_(25-35)介导SH-SY5Y细胞Bcl-2、Bax基因表达改变是否通过基因启动子区甲基化的机制。方法不同浓度Aβ_(25-35)(0、25、50μmol·L^(-1))分别作用于体外培养的SH-SY5Y细胞48、72 h,MTT法确定Aβ_(25-35)诱导SH-SY5Y细胞凋亡的最佳浓度和时间。Western blot检测不同药物处理组细胞凋亡相关蛋白Bcl-2、Bax表达变化,Real time PCR检测DNA甲基化酶DNMT1、DNMT3a、DNMT3b、Me CP2的mRNA水平。Methylation specific PCR(MSP)法分析Aβ_(25-35)介导的Bcl-2、Bax基因启动子区甲基化水平的变化。结果 25μmol·L^(-1)Aβ_(25-35)暴露SH-SY5Y细胞72 h后,MTT检测细胞存活率达(68.49±9.83)%,与对照组比较明显降低(P<0.05),表明成功建立了AD细胞凋亡模型。Western blot结果显示,Aβ_(25-35)药物处理组与空白组比较,Bcl-2表达明显减少,Bax表达明显增加。Real-time PCR结果显示,不同浓度的Aβ_(25-35)药物组与空白组比较,DNA甲基化酶DNMT1、DNMT3a、DNMT3b、MeC P2表达无变化(P<0.05);MSP结果显示空白对照组Bcl-2和Bax甲基化扩增阴性,非甲基化扩增阳性;Aβ_(25-35)处理组Bcl-2和Bax甲基化引物扩增阴性,非甲基化引物扩增阳性。结论 MSP结果显示Aβ_(25-35)介导SHSY5Y细胞凋亡未引起Bcl-2、Bax启动子区甲基化的改变。 Aim To investigate whether the effect of Aβ25-35 on Bcl-2 and Bax gene transcription through DNA methylation in SH-SY5Y cell.Methods Differ-ent concentrations of Aβ25-35 (0, 25, 50 μmol·L-1 ) were treated with SH-SY5Y cells for 48 h or 72 h in vitro.The optimal concentration and time of Aβ25-35 in-duced SH-SY5 Y apoptosis were determined by MTT method.Protein expression levels of Bcl-2 and Bax of Aβ25-35-treated groups were determined by Western blot.Real time PCR was used to detect the mRNA lev-els of DNA methyltransferase including DNMT 1 , DN-MT3a, DMT3b, MeCP2. Methylation specific PCR ( MSP) was used to analyze the effect of Aβ25-35 media-ted Bcl-2 and Bax gene promoter methylation .Results 25 μmol? L-1 Aβ25-35 was exposed to SH-SY5Y cells for 72 h, MTT assay showed that cell viability was (68.49 ±9.83 )%, which was significantly reduced compared with the control group ( P 〈0.05 ) , indica-ting AD cell apoptosis model was successfully estab-lished.Bcl-2 expression of Aβ25-35-treated group was significantly reduced compared with the control group , on the contrary , the expression of Bax was significantly increased .Real-time PCR results showed that com-pared with the control group , DNMT1, DNMT3a, DMT3b, MeCP2 mRNA levels of the Aβ25-35-treated groups had no significant difference ( P〉0.05 ); MSP results showed that Bcl-2 and Bax unmethylated ampli-fication was positive , methylated amplification was neg-ative in control group , Bcl-2 and Bax unmethylated amplification was positive and methylated amplification was negative in Aβ25-35-treated group.Conclusion DNA methylation of Bcl-2 and Bax gene promoter are not affected during Aβ25-35 induced SH-SY5Y cell ap-optosis .
出处 《中国药理学通报》 CAS CSCD 北大核心 2016年第8期1158-1164,共7页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81260650,81560685) 内蒙古自然科学基金资助项目(No 2014BS0805)
关键词 SH-SY5Y细胞 amyloid-β 凋亡 DNA甲基化 DNA甲基化酶 Bcl-2 Bax SH - SY5Y cells amyloid- apoptosis D N A methylation DNMTs Bcl-2 Bax
  • 相关文献

参考文献2

二级参考文献42

  • 1Wenk GL. Neuropathologic changes in Alzheimer's dis- ease. J Clin Psychiatry, 2003, 64(Suppl.9): 7-10.
  • 2Irier HA, Jin P. Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol, 2012, 3 1(Suppl. 1): S42-S48.
  • 3Ramser EM, Gan KJ, Decker H, Fan EY, Suzuki MM, Ferreira ST, Silverman MA. Amyloid-beta oligomers in- duce tan-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocam- pal neurons. Mol Biol Cell, 2013, 24(16): 2494-2505.
  • 4Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256(5054): 184-185.
  • 5Resende R, Marques SCF, Ferreiro E, Sim6es I, Oliveira CR, Pereira CMF. Effect of alphasynuclein on amyloid beta-induced toxicity: relevance to Lewy body variant of Alzheimer disease. Neurochem Res, 2013, 38(4): 797-806.
  • 6Caesar I, Jonson M, Nilsson KPR, Thor S, Hammarstrom P. Curcumin promotes A-beta fibrillation and reduces neurotoxi- city in transgenic Drosophila. PLoS ONE, 2012, 7(2): e31424.
  • 7Rutten BP, Hammels C, Geschwind N, Menne-Lothmann C, Pishva E, Schruers K, van den Hove D, Kenis G, van Os J, Wichers M. Resilience in mental health: linking psy- chological and neurobiological perspectives. Acta Psychiatr Scand, 2013, 128(1): 13-20.
  • 8Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Finessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 1995, 375(6534): 754-760.
  • 9Ringman JM, Coppola G. New genes and new insights from old genes: update on Alzheimer disease. Continuum (Minneap Minn), 2013, 19(2 Dementia): 358-371.
  • 10Goldberg AD, Allis CD, Bernstein E. Epigenetics: a land- scape takes shape. Cell, 2007, 128(4): 635-638.

共引文献10

同被引文献23

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部